Placental/umbilical cord blood (PCB) stem cells for transplantation: Early clinical outcomes and the status of ex vivo expansion strategies

Keio Journal of Medicine

Volumn 49, Issue 4, 2000, Pages 141-151

  Von Drygalski, Annette ^a   Adamson, John W ^a  

^a BLOOD RESEARCH INSTITUTE   (United States)

Author keywords

Bone marrow transplantation; Ex vivo expansion; Mobilized peripheral blood transplantation; Umbilical cord blood transplantation

Indexed keywords

ADULT; ANIMAL; CELL DIVISION; CYTOLOGY; FEMALE; FETUS BLOOD; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TEST; HUMAN; IN VITRO STUDY; NEWBORN; PLACENTA; PREGNANCY; REVIEW; VASCULARIZATION;

ADULT; ANIMALS; CELL DIVISION; FEMALE; FETAL BLOOD; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HISTOCOMPATIBILITY TESTING; HUMANS; INFANT, NEWBORN; PLACENTA; PREGNANCY;

EID: 0034567479     PISSN: 00229717     EISSN: None     Source Type: Journal    
DOI: 10.2302/kjm.49.141     Document Type: Review

References (100)

1. Thomas ED: Karnofsky Memorial Lecture. Marrow transplantation for malignant diseases. J Clin Oncol 1983; 1: 517-531
2. O'Reilly RJ: Allogenic bone marrow transplantation: current status and future directions. Blood 1983; 62: 941-964
3. Kernan NA, Bartsch G, Ash RC, Beatty PG, Champlin R, Filipovich A, Gajewski J, Hansen JA, Henslee-Downey J, McCullough J, et al.: Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med 1993; 328: 593-602
4. Broxmeyer HE, Kurtzberg J, Gluckman E, Auerbach AD, Douglas G, Cooper S, Falkenburg JH, Bard J, Boyse EA: Umbilical cord blood hematopoietic stem and repopulating cells in human clinical transplantation. Blood Cells 1991; 17: 313-329
5. Gluckman E, Broxmeyer HA, Auerbach AD, Friedman HS, Douglas GW, Devergie A, Esperou H, Thierry D, Socie G, Lehn P, et al.: Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 1989; 321: 1174-1178
6. Bensinger W, Singer J, Appelbaum F, Lilleby K, Longin K, Rowley S, Clarke E, Clift R, Hansen J, Shields T, et al.: Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte stimulating factor. Blood 1993; 81: 3158-3163
7. Bensinger WI, Longin K, Appelbaum F, Rowley S, Weaver C, Lilleby K, Gooley T, Lynch M, Higano T, Klarnet J, et al.: Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte stimulating factor (rhG-CSF): an analysis of factors correlating with the tempo of engraftment after transplantation. Br J Haematol 1994; 87: 825-831
8. Bensinger WI, Weaver CH, Appelbaum FR, Rowley S, Demirer T, Sanders J, Storb R, Buckner CD: Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 1995; 85: 1655-1658
9. Wagner JE, Kernan NA, Steinbuch M, Broxmeyer HE, Gluckman E: Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant diseases. Lancet 1995; 346: 214-219
10. Rubinstein P, Rosenfield RE, Adamson JW, Stevens CE: Stored placental blood for unrelated bone marrow reconstitution. Blood 1993; 81: 1679-1690
11. Gluckman E, Wagner J, Hows J, Kernan N, Bradley B, Broxmeyer HE: Cord blood banking for hematopoietic stem cell transplantation: an international cord blood transplant registry. Bone Marrow Transplant 1993; 11: 199-200
12. Catani L, Gugliotta L, Campanini E, Mangianti S, Gibellini D, Baravelli S, Vianelli N, Lemoli RM, Tura S: Megakaryocyte progenitors derived from bone marrow or G-CSF-mobilized peripheral blood CD34 cells show a distinct phenotype and responsiveness to interleukin-3 (IL-3) and PEG-recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF). Br J Haematol 1998; 100: 207-218
13. Urashima M, Hoshi Y, Akiyama M, Kamijo M, Shishikura A, Kato Y, Akatsuka J, Maekawa K: Effects of cytokines on hematopoietic progenitor cells in cord blood, in bone marrow, and in peripheral blood mobilized by chemotherapy and G-CSF. Acta Paediatr Jpn 1995; 37: 21-26
14. Gehling UM, Ryder JW, Hogan CJ, Hami L, McNiece I, Franklin W, Williams S, Helm K, King J, Shpall EJ: Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood. Exp Hematol 1997; 25: 1125-1139
15. Hao QL, Shah AJ, Thiemann FT, Smogorzewska EM, Crooks GM: A functional comparison of CD34+ CD38-cells in cord blood and bone marrow. Blood 1995; 86: 3745-3753
16. Van Epps DE, Bender J, Lee W, Schilling M, Smith A, Smith S, Unverzagt K, Law P, Burgess J: Harvesting, characterization, and culture of CD34+ cells from human bone marrow, peripheral blood, and cord blood. Blood Cells 1994; 20: 411-423
17. van de Ven C, Ishizawa L, Law P, Cairo MS: IL-11 in combination with SLF and G-CSF or GM-CSF significantly increases expansion of isolated CD34+ cell population from cord blood vs. adult bone marrow. Exp Hematol 1995; 23: 1289-1295
18. Liu J, Li K, Yuen PM, Fok TF, Yau FW, Yang M, Li CK: Ex vivo expansion of enriched CD34+ cells from neonatal blood in the presence of thrombopoietin, a comparison with cord blood and bone marrow. Bone Marrow Transplant 1999; 24: 247-252
19. Bender JG, Unverzagt K, Walker DE, Lee W, Smith S, Williams S, Van Epps DE: Phenotypic analysis and characterization of CD34+ cells from normal human bone marrow, cord blood, peripheral blood, and mobilized peripheral blood from patients undergoing autologous stem cell transplantation. Clin Immunol Immunopathol 1994; 70: 10-18
20. Steen R, Tjonnfjord GE, Egeland T: Comparison of the phenotype and clonogenicity of normal CD34+ cells from umbilical cord blood, granulocyte colony-stimulating factor-mobilized peripheral blood, and adult human bone marrow. J Hematother 1994; 3: 253-262
21. De Bruyn C, Delforge A, Bron D, Bernier M, Massy M, Ley P, de Hemptinne D, Stryckmans P: Comparison of the coexpression of CD38, CD33 and HLA-DR antigens on CD34+ purified cells from human cord blood and bone marrow. Stem Cells 1995; 13: 281-288
22. Drygalski A, Xu G, Constantinescu D, Kashiwakura I, Farley T, Dobrila L, Rubinstein P, Adamson JW: The frequency and proliferative potential of megakaryocytic colony-forming cells (Meg-CFC) in cord blood, cytokine-mobilized peripheral blood and bone marrow, and their correlation with total CFC numbers: implications for the quantitation of meg-CFC to predict platelet engraftment following cord blood transplantation. Bone Marrow Transplant 2000; 25: 1029-1034
23. Ratajczak J, Machalinski B, Samuel A, Pertusini E, Majka M, Czajka R, Ratajczak MZ: A novel serum free system for cloning human megakaryocytic progenitors (CFU-Meg). The role of thrombopoietin and other cytokines on bone marrow and cord blood CFU-Meg growth under serum free conditions. Folia Histochem Cytobiol 1998; 36: 61-66
24. Gordon MY, Lewis JL, Scott MA, Roberts IA, Goldman JM: Probability of progenitor renewal (PPR) and production of clonogenic progeny (CFU-GM) by primitive adherent progenitor cells in adult human bone marrow and umbilical cord blood. Br J Haematol 1995; 90, 744-749
25. Migliaccio G, Baiocchi M, Hamel N, Eddleman K, Migliaccio AR: Circulating progenitor cells in human ontogenesis: response to growth factors and replating potential. J Hematother 1996; 5: 161-170
26. Wyrsch A, dalle Carbonare V, Jansen W, Chklovskaia E, Nissen C, Surbek D, Holzgreve W, Tichelli A, Wodnar-Filipowicz A: Umbilical cord blood from preterm human fetuses is rich in committed and primitive hematopoietic progenitors with high proliferative and self-renewal capacity. Exp Hematol 1999; 27: 1338-1345
27. Migliaccio G, Migliaccio AR, Druzin ML, Giardina PJ, Zsebo KM, Adamson JW: Effects of recombinant human stem cell factor (SCF) on the growth of human progenitor cells in vitro. J Cell Physiol 1991; 148: 503-509
28. Migliaccio G, Migliaccio AR, Druzin ML, Giardina PJ, Zsebo KM, Adamson JW: Long-term generation of colony-forming cells in liquid culture of CD34+ cord blood cells in the presence of recombinant human stem cell factor. Blood 1992; 79: 2620-2627
29. Wang JC, Doedens M, Dick JE: Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo SCID-repopulating cell assay. Blood 1997; 89: 3919-3924
30. Vaziri H, Dragowska W, Allsopp RC, Thomas TE, Harley CB, Lansdorp PM: Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci USA 1994; 91: 9857-9860
31. Zandstra PW, Conneally E, Piret JM, Eaves CJ: Ontogeny-associated changes in the cytokine responses of primitive human haemopoietic cells. Br J Haematol 1998; 101: 770-778
32. Lansdorp PM, Dragowska W, Mayani H: Ontogeny-related changes in proliferative potential of human hematopoietic cells. J Exp Med 1993; 178: 787-791
33. Deutsch VR, Olson TA, Nagler A, Slavin S, Levine RF, Eldor A: The response of cord blood megakaryocyte progenitors to IL-3, IL-6 and aplastic canine serum varies with gestational age. Br J Haematol 1995; 89: 8-16
34. Weekx SF, Van Bockstaele DR, Plum J, Moulijn A, Rodrigus I, Lardon F, De Smedt M, Nijs G, Lenjou M, Loquet P, Berneman ZN, Snoeck HW: CD34++ CD38- and CD34+ CD38+ human hematopoietic progenitors from fetal liver, cord blood, and adult bone marrow respond differently to hematopoietic cytokines depending on the ontogenic source. Exp Hematol 1998; 26: 1034-1042
35. Nishihira H, Toyoda Y, Miyazaki H, Kigasawa H, Ohsaki E: Growth of macroscopic human megakaryocyte colonies from cord blood in culture with recombinant human thrombopoietin (c-mpl ligand) and the effects of gestational age on frequency of colonies. Br J Haematol 1996; 92: 23-28
36. Kurtzberg J, Laughlin M, Graham ML, Smith C, Olson JF, Halperin EC, Ciocci G, Carrier C, Stevens CE, Rubinstein P: Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 1996; 335: 157-165
37. Gluckman E, Rocha V, Boyer-Chammard A, Locatelli F, Arcese W, Pasquini R, Ortega J, Souillet G, Ferreira E, Laporte JP, Fernandez M, Chastang C: Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N Engl J Med 1997; 337: 373-381
38. Rubinstein P, Carrier C, Scaradavou A, Kurtzberg J, Adamson J, Migliaccio AR, Berkowitz RL, Cabbad M, Dobrila NL, Taylor PE, Rosenfield RE, Stevens CE: Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998; 339: 1565-1577
39. Locatelli F, Rocha V, Chastang C, Arcese W, Michel G, Abecasis M, Messina C, Ortega J, Badell-Serra I, Plouvier E, Souillet G, Jouet JP, Pasquini R, Ferreira E, Gamier F, Gluckman E: Factors associated with outcome after cord blood transplantation in children with acute leukemia. Eurocord-Cord Blood Transplant Group. Blood 1999; 93: 3662-3671
40. Wagner JE, Rosenthal J, Sweetman R, Shu XO, Davies SM, Ramsay NK, McGlave PB, Sender L, Cairo MS: Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease. Blood 1996; 88: 795-802
41. Davies SM, Wagner JE, Shu XO, Blazar BR, Katsanis E, Orchard PJ, Kersey JH, Dusenbery KE, Weisdorf DJ, McGlave PB, Ramsay NK: Unrelated donor bone marrow transplantation for children with acute leukemia. J Clin Oncol 1997; 15: 557-565
42. Balduzzi A, Gooley T, Anasetti C, Sanders JE, Martin PJ, Petersdorf EW, Appelbaum FR, Buckner CD, Matthews D, Storb R et al.: Unrelated donor marrow transplantation in children. Blood 1995; 86: 3247-3256
43. To LB, Roberts MM, Haylock DN, Dyson PG, Branford AL, Thorp D, Ho JQ, Dart GW, Horvath N, Davy ML, et al.: Comparison of hematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants. Bone Marrow Transplant 1992; 9: 277-284
44. Weaver CH, Hazelton B, Birch R, Palmer P, Allen C, Schwartzberg L, West W: An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood 1995; 86: 3961-3969
45. 6/kg CD34+ cells for autologous stem cell transplantation significantly reduces febrile complications and use of antibiotics after transplantations. Bone Marrow Transplant 1999; 23: 1177-1181
46. Glaspy J, McNiece I, LeMaistre F, Menchaca D, Briddell R, Lill M, Jones R, Tami J, Morstyn G, Brown S, Shpall EJ: Effects of stem cell factor (rhSCF) and filgrastim (rhG-CSF) on mobilization of peripheral blood progenitor cells (PBPC) and on hematological recovery posttransplant: early results from a phase I/II study. Program/Proceedings of the ASCO 1994; 13: 68
47. Briddell R, Glaspy J, Shpall EJ, LeMaistre F, Menchaca D, McNiece I: Mobilization of myeloid, erythroid and megakaryocyte progenitors by recombinant human stem cell factor (rhSCF) plus Filgrastim (rhG-CSF) in patients with breast cancer. Program/Proceedings of the ASCO 1994; 13: 77
48. Briddell R, Glaspy J, Shpall EJ, LeMaistre F, Menchaca D, McNiece I: Treatment of breast cancer patients with stem cell factor (rhSCF) and filgrastim (rhG-CSF) mobilizes increased numbers of megakaryocyte progenitors. Cord Blood 1994; 22: 683
49. Feng R, Shimazaki C, Inaba T, Takahashi R, Hirai H, Kikuta T, Sumikuma T, Yamagata N, Ashihara E, Fujita N, Nakagawa M: CD34+/CD41a+ cells best predict platelet recovery after autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 1998; 21: 1217-1222
50. Migliaccio AR, Adamson JW, Rubinstein P, Stevens C: Correlations between progenitor cell dose, likelihood to engraft and time to myeloid engraftment in 79 unrelated placental/cord blood transplants. Cord Blood 1997; 25: 830
51. Capmany G, Querol S, Cancelas JA, Garcia J: Short-term, serum-free, static culture of cord blood-derived CD34+ cells: effects of Flt3-L and MIP-1 alpha on in vitro expansion of hematopoietic progenitor cells. Haematologica 1999; 84: 675-682
52. De Felice L, Di Pucchio T, Mascolo MG, Agostini F, Breccia M, Guglielmi C, Ricciardi MR, Tafuri A, Screnci M, Mandelli F, Arcese W: Flt3LP3 induces the ex-vivo amplification of umbilical cord blood committed progenitors and early stein cells in short-term cultures. Br J Haematol 1999; 106: 133-141
53. van den Oudenrijn S, de Haas M, Calafat J, van der School CE, von dem Borne AE: A combination of megakaryocyte growth and development factor and interleukin-1 is sufficient to culture large numbers of megakaryocytic progenitors and megakaryocytes for transfusion purposes. Br J Haematol 1999; 106: 553-563
54. Giarratana MC, Kobari L, Neildez Nguyen TM, Firat H, Bouchet S, Lopez M, Gorin NC, Thierry D, Douay L: Cell culture bags allow a large extent of ex vivo expansion of LTC-IC and functional mature cells which can subsequently be frozen: interest for a large-scale clinical applications. Bone Marrow Transplant 1998; 22: 707-715
55. Koller MR, Manchel I, Maher RJ, Goltry KL, Armstrong RD, Smith AK: Clinical-scale human umbilical cord blood cell expansion in a novel automated perfusion culture system. Bone Marrow Transplant 1998; 21: 653-663
56. Mobest D, Mertelsmann R, Henschler R: Serum-free ex vivo expansion of CD34(+) hematopoietic progenitor cells. Biotechnol Bioeng 1998; 60: 341-347
57. Paquette RL, Gonzales E, Yoshimura R, Tran L, Choi R, Baldwin G, Slamon DJ, Glaspy J: Ex vivo expansion and differentiation of unselected peripheral blood progenitor cells in serum-free media. J Hematother 1998; 7: 481-491
58. David S, Boiron JM, Dupouy M, Rice A, Vianes I, Duperray V, Reiffers J: Expansion of blood CD34+ cells: committed precursor expansion does not affect immature hematopoietic progenitors. J Hematother 1997; 6: 151-158
59. Ahmed N, Khokher MA, Hassan HT: Cytokine-induced expansion of human CD34+ stem/progenitor and CD34+CD41+ early megakaryocytic marrow cells cultured on normal osteoblasts. Stem Cells 1999; 17: 92-99
60. Breems DA, Blokland EA, Siebel KE, Mayen AE, Engels LJ, Ploemacher RE: Stroma-contact prevents loss of hematopoietic stem cell quality during ex vivo expansion of CD34+ mobilized peripheral blood stem cells. Blood 1998; 91: 111-117
61. Brandt JE, Galy AH, Luens KM, Travis M, Young J, Tong J, Chen S, Davis TA, Lee KP, Chen BP, Tushinski R, Hoffman R: Bone marrow repopulation by human marrow stem cells after long-term expansion culture on a porcine endothelial cell line. Exp Hematol 1998; 26: 950-961
62. Piacibello W, Sanavio F, Garetto L, Severino A, Dane A, Gammaitoni L, Aglietta M: Differential growth factor requirement of primitive cord blood hematopoietic stem cell for self-renewal and amplification vs proliferation and differentiation. Leukemia 1998; 12: 718-727
63. Haylock DN, To LB, Dowse TL, Juttner CA, Simmons PJ: Ex vivo expansion and maturation of peripheral blood CD34+ cells into the myeloid lineage. Blood 1992; 80: 1405-1412
64. Ruggieri L, Heimfeld S, Broxmeyer HE: Cytokine-dependent ex vivo expansion of early subsets of CD34+ cord blood myeloid progenitors is enhanced by cord blood plasma, but expansion of the more mature subsets of progenitors is favored. Blood Cells 1994; 20: 436-454
65. Szilvassy SJ, Bass MJ, Van Zant G, Grimes B: Organ-selective homing defines engraftment kinetics of murine hematopoietic stem cells and is compromised by ex vivo expansion. Blood 1999; 93: 1557-1566
66. Dick JE, Bhatia M, Gan O, Kapp U, Wang JC: Assay of human stem cells by repopulation of NOD/SCID mice. Stem Cells 1997; 15 (Suppl 1): 199-203
67. Bonnet D, Bhatia M, Wang JC, Kapp U, Dick JE: Cytokine treatment or accessory cells are required to initiate engraftment of purified primitive human hematopoietic cells transplanted at limiting doses into NOD/SCID mice. Bone Marrow Transplant 1999; 23: 203-209
68. Piacibello W, Sanavio F, Garetto L, Severino A, Bergandi D, Ferrario J, Fagioli F, Berger M, Aglietta M: Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood. Blood 1997; 89: 2644-2653
69. Piacibello W, Sanavio F, Severino A, Dane A, Gammaitoni L, Fagioli F, Perissinotto E, Cavalloni G, Kollet O, Lapidot T, Aglietta M: Engraftment in nonobese diabetic severe combined immunodeficient mice of human CD34(+) cord blood cells after ex vivo expansion: evidence for the amplification and self-renewal of repopulating stem cells. Blood 1999; 93: 3736-3749
70. Bhatia M, Bonnet D, Kapp U, Wang JC, Murdoch B, Dick JE: Quantitative analysis reveals expansion of human hematopoietic repopulating cells after short-term ex vivo culture. J Exp Med 1997; 186: 619-624
71. Mobest D, Goan SR, Junghahn I, Winkler J, Fichtner I, Hermann M, Becker M, de Lima-Hahn E, Henschler R: Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells. Stem Cells 1999; 17: 152-161
72. Albella B, Segovia JC, Guenechea G, Pragnell IB, Bueren JA: Preserved long-term repopulation and differentiation properties of hematopoietic grafts subjected to ex vivo expansion with stem cell factor and interleukin 11. Transplantation 1999; 67: 1348-1357
73. Guenechea G, Segovia JC, Albella B, Lamana M, Ramirez M, Regidor C, Fernandez MN, Bueren JA: Delayed engraftment of nonobese diabetic/severe combined immunodeficient mice transplanted with ex vivo-expanded human CD34(+) cord blood cells. Blood 1999; 93: 1097-1105
74. Kogler G, Callejas J, Sorg RV, Fischer J, Migliaccio AR, Wernet P: The effect of different thawing methods, growth factor combinations and media on the ex vivo expansion of umbilical cord blood primitive and committed progenitors. Bone Marrow Transplant 1998; 21: 233-241
75. Pick M, Nagler A, Grisaru D, Eldor A, Deutsch V: Expansion of megakaryocyte progenitors from human umbilical cord blood using a new two-step separation procedure. Br J Haematol 1998; 103: 639-650
76. Engel H, Kaya E, Bald R, Kolhagen H, Grecu O, Schondorf T, Brenne U, Kurbacher CM, Gohring UJ, Kleine M, Mallmann P: Fetal cord blood as an alternative source of hematopoietic progenitor cells: immunophenotype, maternal cell contamination, and ex vivo expansion. J Hematother 1999; 8: 141-155
77. Muench MO, Moore MA: Accelerated recovery of peripheral blood cell counts in mice transplanted with in vitro cytokine-expanded hematopoietic progenitors. Exp Hematol 1992; 20: 611-618
78. Muench MO, Firpo MT, Moore MA: Bone marrow transplantation with interleukin-1 plus kit-ligand ex vivo expanded bone marrow accelerates hematopoietic reconstitution in mice without the loss of stem cell lineage and proliferative potential. Blood 1993; 81: 3463-3473
79. Holyoake TL, Freshney MG, McNair L, Parker AN, McKay PJ, Steward WP, Fitzsimons E, Graham GJ, Pragnell IB: Ex vivo expansion with stem cell factor and interleukin-11 augments both short-term recovery posttransplant and the ability to serially transplant marrow. Blood 1996; 87: 4589-4595
80. Ratajczak MZ, Ratajczak J, Machalinski B, Mick R, Gewirtz AM: In vitro and in vivo evidence that ex vivo cytokine priming of donor marrow cells may ameliorate posttransplant thrombocytopenia. Blood 1998; 91: 353-359
81. Szilvassy SJ, Weller KP, Chen B, Juttner CA, Tsukamoto A, Hoffman R: Partially differentiated ex vivo expanded cells accelerate hematologic recovery in myeloablated mice transplanted with highly enriched long-term repopulating stem cells. Blood 1996; 88: 3642-3653
82. Albella B, Segovia JC, Bueren JA: Does the granulocyte-macrophage colony-forming unit content in ex vivo-expanded grafts predict the recovery of the recipient leukocytes? Blood 1997; 90: 464-470
83. Peters SO, Kittler EL, Ramshaw HS, Quesenberry PJ: Ex vivo expansion of murine marrow cells with interleukin-3 (IL-3), IL-6, IL-11, and stem cell factor leads to impaired engraftment in irradiated hosts. Blood 1996; 87: 30-37
84. Traycoff CM, Cornetta K, Yoder MC, Davidson A, Srour EF: Ex vivo expansion of murine hematopoietic progenitor cells generates classes of expanded cells possessing different levels of bone marrow repopulating potential. Exp Hematol 1996; 24: 299-306
85. Knobel KM, McNally MA, Berson AE, Rood D, Chen K, Kilinski L, Tran K, Okarma TB, Lebkowski JS: Long-term reconstitution of mice after ex vivo expansion of bone marrow cells: differential activity of cultured bone marrow and enriched stem cell populations. Exp Hematol 1994; 22: 1227-1235
86. Tisdale JF, Hanazono Y, Sellers SE, Agricola BA, Metzger ME, Donahue RE, Dunbar CE: Ex vivo expansion of genetically marked rhesus peripheral blood progenitor cells results in diminished long-term repopulating ability. Blood 1998; 92: 1131-1141
87. Brandt JE, Bartholomew AM, Fortman JD, Nelson MC, Bruno E, Chen LM, Turian JV, Davis TA, Chute JP, Hoffman R: Ex vivo expansion of autologous bone marrow CD34(+) cells with porcine microvascular endothelial cells results in a graft capable of rescuing lethally irradiated baboons. Blood 1999; 94: 106-113
88. Abkowitz JL, Taboada MR, Sabo KM, Shelton GH: The ex vivo expansion of feline marrow cells leads to increased numbers of BFU-E and CFU-GM but a loss of reconstituting ability. Stem Cells 1998; 16: 288-293
89. Kurtzberg J, Jaroscak J, Martin PL, Driscoll T, Waters-Pick B, Douville J, Howrey R, Goltry KL, Smith AK: Augmentation of umbilical cord blood (UCB) transplantation with ex vivo expanded cells, a phase I trial using the Replicell System. Cord Blood Special Session 1999; 94: 571 abstract
90. Brugger W, Heimfeld S, Berenson RJ, Mertelsmann R, Kanz L: Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo. N Engl J Med 1995; 333: 283-287
91. Alcorn MJ, Holyoake TL, Richmond L, Pearson C, Farrell E, Kyle B, Dunlop DJ, Fitzsimons E, Steward WP, Pragnell IB, Franklin IM: CD34-positive cells isolated from cryopreserved peripheral-blood progenitor cells can be expanded ex vivo and used for transplantation with little or no toxicity. J Clin Oncol 1996; 14: 1839-1847
92. Stiff P, Oldenberg D, Hsi E, Chen B, Smith A, Bayer R, Malhotra D, Kerger C, Armstrong RD, Muller T: Transplantation of ex vivo expanded cells grown in Aastrom stromal-based perfusion bioreactors from small marrow aliquots (40 ml) produces durable hematopoietic reconstitution after ablative chemotherapy. Experimental Transplantation-GVHD and GVL Effector Mechanisms 1997; 90: 395 abstract
93. Williams SF, Lee WJ, Bender JG, Zimmerman T, Swinney P, Blake M, Carreon J, Schilling M, Smith S, Williams DE, Oldham F, Van Epps D: Selection and expansion of peripheral blood CD34+ cells in autologous stem cell transplantation for breast cancer. Blood 1996; 87: 1687-1691
94. Bertolini F, Battaglia M, Pedrazzoli P, Da Prada GA, Lanza A, Soligo D, Caneva L, Sarina B, Murphy S, Thomas T, della Cuna GR: Megakaryocytic progenitors can be generated ex vivo and safely administerd to autologous peripheral blood progenitor cell transplant recipients. Blood 1997; 89: 2679-2688
95. Lazarus HM, Haynesworth SE, Gerson SL, Rosenthal NS, Caplan AI: Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use. Bone Marrow Transplant 1995; 16: 557-564
96. Bachier CR, Gokmen E, Teale J, Lanzkron S, Childs C, Franklin W, Shpall E, Douville J, Weber S, Muller T, Armstrong D, LeMaistre CF: Ex-vivo expansion of bone marrow progenitor cells for hematopoietic reconstitution following high-dose chemotherapy for breast cancer. Exp Hematol 1999; 27: 615-623
97. McNiece I, Jones R, Cagnoni P, Bearman S, Nieto Y, Shpall EJ: Ex-vivo expansion of hematopoietic progenitor cells: preliminary results in breast cancer. Hematol Cell Ther 1999; 41: 82-86
98. Lundell BI, Vredenburgh JJ, Tyer C, DeSombre K, Smith AK: Ex vivo expansion of bone marrow from breast cancer patients: reduction in tumor cell content through passive purging. Bone Marrow Transplant 1998; 22: 153-159
99. Muench MO, Guy Z, Moore MA: Ex vivo differentiation therapy as a method of leukemic cell purging in murine bone marrow expansion cultures. Cancer Res 1992, 52: 6576-6582
100. Spyridonidis A, Bernhardt W, Behringer D, Kohler G, Azemar M, Pflug A, Henschler R: Proliferation and survival of mammary carcinoma cells are influenced by culture conditions used for ex vivo expansion of CD34(+) blood progenitor cells. Blood 1999; 93: 746-755